8551 - 8560 of 9131 Results
Title
Year
-
OPENTitle: Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. centerJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 15Issue #:Start Page: 100492End Page: 100492Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100492Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2590112526000721/pdfCitation Count: 0
-
OPENTitle: Shortened olfactory identification testing to differentiate parkinsonian syndromesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 149Issue #:Start Page: 108372End Page: 108372Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108372Best OA location URL: https://doi.org/10.1016/j.parkreldis.2026.108372Citation Count: 0
-
OPENTitle: Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 228Issue #:Start Page: 107570End Page: 107570Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2026.107570Best OA location URL: https://doi.org/10.1016/j.nbd.2026.107570Citation Count: 0
-
OPENTitle: Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implicationsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 8Start Page: 741End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(26)00198-5Best OA location URL: https://doi.org/10.1016/s1474-4422(26)00198-5Citation Count: 1
- New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment2026RESTRICTEDTitle: New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatmentJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 6Start Page: 602End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00090-6Citation Count: 2
-
OPENTitle: The structural basis for LRRK2’s activation and autoinhibitionJournal Name: CellPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cell.2026.07.027Best OA location URL: https://doi.org/10.1016/j.cell.2026.07.027Citation Count: 0
-
OPENTitle: STING dampens the unfolded protein response to enable the presentation of self-antigens on MHC-I during inflammationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 45Issue #: 6Start Page: 117497End Page: 117497Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2026.117497Best OA location URL: https://doi.org/10.1016/j.celrep.2026.117497Citation Count: 0
- Exploring the association between antidepressants, progression and mortality in Huntington’s disease2026OPENTitle: Exploring the association between antidepressants, progression and mortality in Huntington’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 8Start Page: 2680End Page: 2688Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awag009Best OA location URL: https://doi.org/10.1093/brain/awag009Citation Count: 0
-
OPENTitle: Distinct proteomic CSF profiles in genetic frontotemporal lobar degenerationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaf457Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf457/65752716/awaf457.pdfCitation Count: 1
-
OPENTitle: 5-HT 4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of AcetylcholinesteraseJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 17Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.6c00342Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.6c00342?ref=article_openPDFCitation Count: 0